41118-19-8

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 4-oxochromane-6-carboxylate is used as a chemical intermediate for the development of novel drugs and medicinal chemistry research. Its unique structure and properties make it a promising candidate for the creation of new pharmaceutical compounds.
Used in Medicinal Chemistry Research:
Methyl 4-oxochromane-6-carboxylate is used as a research tool to study the reactivity and potential biological activities of chromane derivatives. This helps scientists to better understand the mechanisms of action and therapeutic potential of these compounds.
Further research and testing are needed to fully explore the potential uses of Methyl 4-oxochromane-6-carboxylate in various applications.

Upstream product

• 67-56-1 methanol 
• 49660-57-3 6-bromochroman-4-one 
• 201230-82-2 carbon monoxide 
• 90921-08-7 acide chromannone-4 carboxylique-6 
• 41118-24-5 methyl chromane-6-carboxylate 

Relevant academic research and scientific papers

ANTIMALARIAL AGENTS

Methods for treating malaria comprises administration of compounds of Formula (I) or a pharmaceutically acceptable salt thereof, to a subject in need thereof, wherein the variables are as defined herein. It also provides uses of the compounds of Formula (I), as defined herein, for inhibiting plasmepsin X, plasmepsin IX or plasmepsin X and IX activity, for treating a Plasmodium infection, and for treating malaria. Also provided are methods of treatment further comprising administration of one or more additional anti-malarial compounds.

HETEROCYCLIC COMPOUNDS WITH AN ROR(GAMMA)T MODULATING ACTIVITY

The present invention relates to a compound that may have an ROR(gamma)t modulating activity and can thus be useful in the treatment of cancer.

SPIROXAZOLIDINONE COMPOUNDS

Substituted spirocyclic amines of structural formula (I) are selective antagonists of the somatostatin subtype receptor 5 (SSTR5) and are useful for the treatment, control or prevention of disorders responsive to antagonism of SSTR5, such as Type 2 diabetes, insulin resistance, lipid disorders, obesity, atherosclerosis, Metabolic Syndrome, depression, and anxiety.